• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of bmjBMJ helping doctors make better decisionsSearch bmj.comLatest content
BMJ. Dec 14, 1991; 303(6816): 1499–1503.
PMCID: PMC1671862

Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials.

Abstract

OBJECTIVE--To investigate the effect of intravenous magnesium on mortality in suspected acute myocardial infarction. DESIGN--Systematic overview of all available randomised trials in which patients were allocated to receive either intravenous magnesium or otherwise similar treatment without magnesium. SETTING--Coronary care units of several hospitals. PATIENTS--1301 patients in seven randomised trials. MAIN OUTCOME MEASURE--Short term mortality. RESULTS--Considering the seven trials collectively there were 25 (3.8%) deaths among 657 patients allocated to receive magnesium and 53 (8.2%) deaths among 644 patients allocated control, generally during hospital follow up. This represents a 55% reduction in the odds of death (p less than 0.001) with 95% confidence intervals ranging from about one third to about two thirds. 70 of 648 patients allocated magnesium compared with 109 of 641 controls had serious ventricular arrhythmias, suggesting that magnesium reduces the incidence, though the definition varied among trials. Other adverse effects were rare in the limited number of patients for whom this data were available. CONCLUSION--Despite the limited number of patients randomised this overview suggests that intravenous magnesium therapy may reduce mortality in patients with acute myocardial infarction. Further large scale trials to confirm (or refute) these findings are desirable.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Leary WP, Reyes AJ, Lockett CJ, Arbuckle DD, van der Byl K. Magnesium and deaths ascribed to ischaemic heart disease in South Africa. A preliminary report. S Afr Med J. 1983 Nov 5;64(20):775–776. [PubMed]
  • Elwood PC, Sweetnam PM, Beasley WH, Jones D, France R. Magnesium and calcium in the myocardium: cause of death and area differences. Lancet. 1980 Oct 4;2(8197):720–722. [PubMed]
  • Woods KL. Possible pharmacological actions of magnesium in acute myocardial infarction. Br J Clin Pharmacol. 1991 Jul;32(1):3–10. [PMC free article] [PubMed]
  • MISHRA RK. Studies on experimental magnesium deficiency in the albino rat. 1. Functional and morphologic changes as sociated with low intake of Mg. Rev Can Biol. 1960 Jun;19:122–135. [PubMed]
  • Turlapaty PD, Altura BM. Magnesium deficiency produces spasms of coronary arteries: relationship to etiology of sudden death ischemic heart disease. Science. 1980 Apr 11;208(4440):198–200. [PubMed]
  • Altura BM, Altura BT. Influence of magnesium on drug-induced contractions and ion content in rabbit aorta. Am J Physiol. 1971 Apr;220(4):938–944. [PubMed]
  • Turlapaty PD, Altura BM. Extracellular magnesium ions control calcium exchange and content of vascular smooth muscle. Eur J Pharmacol. 1978 Dec 1;52(3-4):421–423. [PubMed]
  • Shine KI. Myocardial effects of magnesium. Am J Physiol. 1979 Oct;237(4):H413–H423. [PubMed]
  • Armstrong BK. Oral contraceptives and breast cancer. Lancet. 1986 Mar 8;1(8480):552–553. [PubMed]
  • Chang C, Varghese PJ, Downey J, Bloom S. Magnesium deficiency and myocardial infarct size in the dog. J Am Coll Cardiol. 1985 Feb;5(2 Pt 1):280–289. [PubMed]
  • Ghani MF, Rabah M. Effect of magnesium chloride on electrical stability of the heart. Am Heart J. 1977 Nov;94(5):600–602. [PubMed]
  • Dyckner T. Serum magnesium in acute myocardial infarction. Relation to arrhythmias. Acta Med Scand. 1980;207(1-2):59–66. [PubMed]
  • Dyckner T, Wester PO. Ventricular extrasystoles and intracellular electrolytes before and after potassium and magnesium infusions in patients on diuretic treatment. Am Heart J. 1979 Jan;97(1):12–18. [PubMed]
  • Perticone F, Adinolfi L, Bonaduce D. Efficacy of magnesium sulfate in the treatment of torsade de pointes. Am Heart J. 1986 Oct;112(4):847–849. [PubMed]
  • Rasmussen HS, Aurup P, Hojberg S, Jensen EK, McNair P. Magnesium and acute myocardial infarction. Transient hypomagnesemia not induced by renal magnesium loss in patients with acute myocardial infarction. Arch Intern Med. 1986 May;146(5):872–874. [PubMed]
  • Hlatky MA, Cotugno HE, Mark DB, O'Connor C, Califf RM, Pryor DB. Trends in physician management of uncomplicated acute myocardial infarction, 1970 to 1987. Am J Cardiol. 1988 Mar 1;61(8):515–518. [PubMed]
  • MacMahon S, Collins R, Peto R, Koster RW, Yusuf S. Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. JAMA. 1988 Oct 7;260(13):1910–1916. [PubMed]
  • Hine LK, Laird N, Hewitt P, Chalmers TC. Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction. Arch Intern Med. 1989 Dec;149(12):2694–2698. [PubMed]
  • Hine LK, Laird NM, Hewitt P, Chalmers TC. Meta-analysis of empirical long-term antiarrhythmic therapy after myocardial infarction. JAMA. 1989 Dec 1;262(21):3037–3040. [PubMed]
  • Morton BC, Nair RC, Smith FM, McKibbon TG, Poznanski WJ. Magnesium therapy in acute myocardial infarction--a double-blind study. Magnesium. 1984;3(4-6):346–352. [PubMed]
  • Rasmussen HS, McNair P, Norregard P, Backer V, Lindeneg O, Balslev S. Intravenous magnesium in acute myocardial infarction. Lancet. 1986 Feb 1;1(8475):234–236. [PubMed]
  • Rasmussen HS, Grønbaek M, Cintin C, Balsløv S, Nørregård P, McNair P. One-year death rate in 270 patients with suspected acute myocardial infarction, initially treated with intravenous magnesium or placebo. Clin Cardiol. 1988 Jun;11(6):377–381. [PubMed]
  • Smith LF, Heagerty AM, Bing RF, Barnett DB. Intravenous infusion of magnesium sulphate after acute myocardial infarction: effects on arrhythmias and mortality. Int J Cardiol. 1986 Aug;12(2):175–183. [PubMed]
  • Abraham AS, Rosenmann D, Kramer M, Balkin J, Zion MM, Farbstien H, Eylath U. Magnesium in the prevention of lethal arrhythmias in acute myocardial infarction. Arch Intern Med. 1987 Apr;147(4):753–755. [PubMed]
  • Shechter M, Hod H, Marks N, Behar S, Kaplinsky E, Rabinowitz B. Beneficial effect of magnesium sulfate in acute myocardial infarction. Am J Cardiol. 1990 Aug 1;66(3):271–274. [PubMed]
  • Ceremuzyński L, Jurgiel R, Kulakowski P, Gebalska J. Threatening arrhythmias in acute myocardial infarction are prevented by intravenous magnesium sulfate. Am Heart J. 1989 Dec;118(6):1333–1334. [PubMed]
  • Collins R, Gray R, Godwin J, Peto R. Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews. Stat Med. 1987 Apr-May;6(3):245–254. [PubMed]
  • Peto R. Why do we need systematic overviews of randomized trials? Stat Med. 1987 Apr-May;6(3):233–244. [PubMed]
  • Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985 Mar-Apr;27(5):335–371. [PubMed]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Group

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • Compound
    Compound
    PubChem Compound links
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...